 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 August 1993 | Volume 119 Issue 3 | Pages 207-214
Objective: To compare the short- and medium-term complications (particularly infection) of bone marrow transplantation for chronic myeloid leukemia in patients with HLA-identical sibling donors or volunteer unrelated donors.
Design: Retrospective review of two cohorts of patients.
Setting: Tertiary referral center.
Patients: One hundred three patients with chronic myeloid leukemia in first chronic phase.
Intervention: Patients were treated with bone marrow transplantation using marrow from HLA-identical siblings (n = 57) and volunteer donors (n = 46).
Main Results: In total, 68 patients survived a median of 22 months from bone marrow transplant (range, 7 to 81 months). The actuarial probabilities of overall survival and leukemia-free survival at 2 years for the sibling donor group were 73% (95% CI, 60% to 86%) and 72% (CI, 60% to 84%), respectively, and for the volunteer donor group, 47% (CI, 31% to 63%) and 42% (CI, 26% to 58%) (P = 0.07 and 0.05, respectively). However, after adjustment for duration of disease, overall and disease-free survival in the two donor groups did not differ significantly. A major problem was an increased incidence of severe viral infection in the volunteer unrelated donor group (19 episodes in 16 of 46 patients compared with 7 episodes in 7 of 57 sibling donor patients, P = 0.01). The actuarial incidence of chronic graft-versus-host disease (GVHD) was higher in volunteer unrelated donor patients (77% [CI, 63% to 91%] compared with 49% [CI, 35% to 63%]; P = 0.02) but that of acute GVHD was not. The median performance status of the survivors in the volunteer donor group is similar to that in the sibling donor group. The incidence of hematologic relapse in both groups so far is low.
Conclusion: Results appear to justify the continued use of volunteer donors in chronic-phase chronic myeloid leukemia, but infection and chronic GVHD are still major problems.
Author and Article Information
From Hammersmith Hospital, London, United Kingdom.
ARTICLE
Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia Using Sibling and Volunteer Unrelated Donors: A Comparison of Complications in the First 2 Years
Requests for Reprints: John M. Goldman, DM, LRF Centre for Adult Leukaemia, Haematology Department, Royal Postgraduate Medical School, DuCane Rd, London W12, ONN, United Kingdom.
Acknowledgments: The authors thank Paul Brookes, Jan Green, and Ed Kaminski for performing the tissue typing and analysis of cytotoxic T-lymphocyte precursor frequencies; Linda Casey, Susan Cleaver and Dr. Dick Goffin for donor searching, and Julie Bungey and Andrew Chase for performing the cytogenetic analyses; and Drs. H. Waldman and G. Hale, Department of Pathology, Cambridge University, Cambridge, United Kingdom, for producing and supplying all monoclonal antibodies of the Campath series used in this study.
Grant Support: Drs. Marks, Cullis, Szydlo, Hughes, and Schwarer were supported by the Leukaemia Research Fund, United Kingdom.
This article has been cited by other articles:
|
|
 |
|
  O. Alpdogan, J. M. Eng, S. J. Muriglan, L. M. Willis, V. M. Hubbard, K. H. Tjoe, T. H. Terwey, A. Kochman, and M. R. M. van den Brink Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation Blood, January 15, 2005; 105(2): 865 - 873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. W. Petersdorf, C. Anasetti, P. J. Martin, T. Gooley, J. Radich, M. Malkki, A. Woolfrey, A. Smith, E. Mickelson, and J. A. Hansen Limits of HLA mismatching in unrelated hematopoietic cell transplantation Blood, November 1, 2004; 104(9): 2976 - 2980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lang, R. Handgretinger, D. Niethammer, P. G. Schlegel, M. Schumm, J. Greil, P. Bader, C. Engel, H. Scheel-Walter, M. Eyrich, et al. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia Blood, February 15, 2003; 101(4): 1630 - 1636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zecca, A. Prete, R. Rondelli, E. Lanino, A. Balduzzi, C. Messina, F. Fagioli, F. Porta, C. Favre, A. Pession, et al. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome Blood, July 30, 2002; 100(4): 1192 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Tabbara, K. Zimmerman, C. Morgan, and Z. Nahleh Allogeneic Hematopoietic Stem Cell Transplantation: Complications and Results Arch Intern Med, July 22, 2002; 162(14): 1558 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Storek, A. Joseph, G. Espino, M. A. Dawson, D. C. Douek, K. M. Sullivan, M. E. D. Flowers, P. Martin, G. Mathioudakis, R. A. Nash, et al. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation Blood, December 15, 2001; 98(13): 3505 - 3512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Alpdogan, C. Schmaltz, S. J. Muriglan, B. J. Kappel, M.-A. Perales, J. A. Rotolo, J. A. Halm, B. E. Rich, and M. R. M. van den Brink Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease Blood, October 1, 2001; 98(7): 2256 - 2265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Handgretinger, P. Lang, M. Schumm, M. Pfeiffer, S. Gottschling, B. Demirdelen, P. Bader, S. Kuci, T. Klingebiel, and D. Niethammer Immunological Aspects of Haploidentical Stem Cell Transplantation in Children Ann. N.Y. Acad. Sci., June 1, 2001; 938(1): 340 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Storek, M. A. Dawson, B. Storer, T. Stevens-Ayers, D. G. Maloney, K. A. Marr, R. P. Witherspoon, W. Bensinger, M. E. D. Flowers, P. Martin, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation Blood, June 1, 2001; 97(11): 3380 - 3389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Akpek, M. L. Zahurak, S. Piantadosi, J. Margolis, J. Doherty, R. Davidson, and G. B. Vogelsang Development of a prognostic model for grading chronic graft-versus-host disease Blood, March 1, 2001; 97(5): 1219 - 1226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Storek, G. Espino, M. A. Dawson, B. Storer, M. E. D. Flowers, and D. G. Maloney Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation Blood, November 1, 2000; 96(9): 3290 - 3293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Craddock, R. M. Szydlo, J. P. Klein, F. Dazzi, E. Olavarria, F. van Rhee, C. Pocock, K. Cwynarski, J. F. Apperley, and J. M. Goldman Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission Blood, July 1, 2000; 96(1): 86 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Management of herpes virus infections following transplantation J. Antimicrob. Chemother., June 1, 2000; 45(6): 729 - 748. [Full Text] [PDF]
|
|
|
|
 |
|
 C de Brabander, J Cornelissen, P A E S. Smitt, C. J Vecht, and M J van den Bent Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors J. Neurol. Neurosurg. Psychiatry, January 1, 2000; 68(1): 36 - 40. [Abstract] [Full Text]
|
|
|
|
|
|
F. Dazzi, R. M. Szydlo, C. Craddock, N. C. P. Cross, J. Kaeda, A. Chase, E. Olavarria, F. van Rhee, E. Kanfer, J. F. Apperley, et al. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia Blood, January 1, 2000; 95(1): 67 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Monitoring Treatment and Survival in Chronic Myeloid Leukemia J. Clin. Oncol., June 1, 1999; 17(6): 1858 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.N. Small, E.B. Papadopoulos, F. Boulad, P. Black, H. Castro-Malaspina, B.H. Childs, N. Collins, A. Gillio, D. George, A. Jakubowski, et al. Comparison of Immune Reconstitution After Unrelated and Related T-Cell-Depleted Bone Marrow Transplantation: Effect of Patient Age and Donor Leukocyte Infusions Blood, January 15, 1999; 93(2): 467 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Lee, C. Anasetti, K. M. Kuntz, J. Patten, J. H. Antin, and J. C. Weeks The Costs and Cost-Effectiveness of Unrelated Donor Bone Marrow Transplantation for Chronic Phase Chronic Myelogenous Leukemia Blood, December 1, 1998; 92(11): 4047 - 4052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kawano, Y. Takaue, A. Watanabe, O. Takeda, K. Arai, E. Itoh, Y. Ohno, T. Teshima, M. Harada, T. Watanabe, et al. Partially Mismatched Pediatric Transplants With Allogeneic CD34+ Blood Cells From a Related Donor Blood, November 1, 1998; 92(9): 3123 - 3130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Morton, T. Gooley, J. A. Hansen, F. R. Appelbaum, B. Bruemmer, J. W. Bjerke, R. Clift, P. J. Martin, E. W. Petersdorf, J. E. Sanders, et al. Association Between Pretransplant Interferon-alpha and Outcome After Unrelated Donor Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase Blood, July 15, 1998; 92(2): 394 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Hansen, T. A. Gooley, P. J. Martin, F. Appelbaum, T. R. Chauncey, R. A. Clift, E. W. Petersdorf, J. Radich, J. E. Sanders, R. F. Storb, et al. Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid Leukemia N. Engl. J. Med., April 2, 1998; 338(14): 962 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Gale, R. Hehlmann, M.-J. Zhang, J. Hasford, J. M. Goldman, H. Heimpel, A. Hochhaus, J. P. Klein, H.-J. Kolb, P. B. McGlave, et al. Survival With Bone Marrow Transplantation Versus Hydroxyurea or Interferon for Chronic Myelogenous Leukemia Blood, March 1, 1998; 91(5): 1810 - 1819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. den Haan, L. M. Meadows, W. Wang, J. Pool, E. Blokland, T. L. Bishop, C. Reinhardus, J. Shabanowitz, R. Offringa, D. F. Hunt, et al. The Minor Histocompatibility Antigen HA-1: A Diallelic Gene with a Single Amino Acid Polymorphism Science, February 13, 1998; 279(5353): 1054 - 1057. [Abstract] [Full Text]
|
|
Article
